The ASM sent comments on the 21st Centurey Cures Initiative to the House Committee on Energy and Commerce.
April 21, 2015 - Energy & Environment Provisions in the America COMPETES Reauthorization Act of 2016
The ASM sent a letter to members of the House Committee on Science, Space and Technology about provisions in the America Competes Reauthorization Act of 2016, H.R. 1806.
The PSAB Committee on Laboratory Practices prepared On The Question of Culturing of Duodenoscopes to address the unique challenges of pathogen identification in cases of infections associated with gastrointestinal endoscopy.
The National Institutes of Health released a request for information (RFI) on optimizing funding policies and “other strategies to improve the impact and sustainability of the NIH-funded biomedical research enterprise.”
The ASM submitted comments in response to the Office of Science and Technology and Policy's request for comment on the impact that the Select Agent Regulations have had on science, technology, and national security, and on the benefits, costs, and limitations of the regulations.
The ASM submitted comments to the Centers for Disease Control on the Biennial Review of the Select Agent Regulations.
On March 27, 2015 the White House released a comprehensive plan that identifies critical actions to be taken by Federal departments and agencies to combat the rise of antibiotic-resistant bacteria.
The ASM sent a letter to Sylvia Mathews Burwell, Secretary of Health and Human Services, Department of Health and Human Services regarding CDC Biosafety recommendations.
The ASM submitted FY 2016 appropriations recommendations to the House and Senate Appropriations Committees.
The Office of Science and Technology Policy released a request for comment on regarding the impact that the Select Agent Regulations (SAR) have had on science, technology, and national security, and on the benefits, costs, and limitations of these regulations.